Avadel Pharmaceuticals (AVDL) Shares Outstanding (Weighted Average) (2016 - 2022)
Historic Shares Outstanding (Weighted Average) for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to $53.0 million.
- Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) rose 4168.92% to $53.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $53.0 million, marking a year-over-year increase of 4168.92%. This contributed to the annual value of $53.0 million for FY2020, which is 4168.92% up from last year.
- Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $53.0 million in Q4 2020, which was up 4168.92% from $58.2 million recorded in Q3 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) peaked at $58.2 million during Q3 2020, and registered a low of $37.3 million during Q4 2018.
- For the 5-year period, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $41.8 million, with its median value being $40.8 million (2017).
- Per our database at Business Quant, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) skyrocketed by 10247169.15% in 2016 and then crashed by 865.08% in 2018.
- Over the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $41.2 million in 2016, then fell by 1.9% to $40.5 million in 2017, then dropped by 7.76% to $37.3 million in 2018, then rose by 0.21% to $37.4 million in 2019, then soared by 41.69% to $53.0 million in 2020.
- Its last three reported values are $53.0 million in Q4 2020, $58.2 million for Q3 2020, and $54.3 million during Q2 2020.